Latest SLC5A2 Stories
NORWALK, Conn., Jan.
Forxiga® (dapagliflozin) approved in Canada - a new treatment that lowers blood glucose and can lead to weight loss(i) and reduced blood pressure for adults living with type 2 diabetes (ii)
NORWALK, Conn., Aug.
Metformin and SGLT2 inhibitors together reduce the blood sugar levels considerably more effectively than either drug alone.
Novel Once-Daily Formulation of Remogliflozin Etabonate Achieves Ideal Safety and Efficacy Profiles RALEIGH, N.C., June 16, 2014 /PRNewswire/ --
RALEIGH, N.C., June 12, 2014 /PRNewswire/ -- Islet Sciences, Inc. (OTCQB: ISLT), a biopharmaceutical company developing
DUBLIN, January 29, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/2qlc2k/lexicons_lx4211) has announced the addition of the "Lexicon's